Literature DB >> 17312078

MRI characterization of myocardial tissue in patients with Fabry's disease.

Massimo Imbriaco1, Letizia Spinelli, Alberto Cuocolo, Simone Maurea, Giacomo Sica, Mario Quarantelli, Antonio Pisani, Raffaele Liuzzi, Bruno Cianciaruso, Massimo Sabbatini, Marco Salvatore.   

Abstract

OBJECTIVE: Fabry's disease is a multisystem X-linked disorder of lysosomal metabolism frequently associated with left ventricular (LV) hypertrophy. In this study, we aimed to assess whether myocardial T2 relaxation time determined by a black blood multiecho multishot MRI sequence could be used to evaluate cardiac involvement in patients with Fabry's disease.
CONCLUSION: Myocardial T2 relaxation time is prolonged in patients with Fabry's disease compared with that of hypertrophic patients and healthy control subjects. MRI may be useful for the characterization of myocardial tissue in patients with Fabry's disease.

Entities:  

Mesh:

Year:  2007        PMID: 17312078     DOI: 10.2214/AJR.05.0442

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy.

Authors:  Piers C A Barker; Sara K Pasquali; Stephen Darty; Richard J Ing; Jennifer S Li; Raymond J Kim; Stephanie DeArmey; Priya S Kishnani; Michael J Campbell
Journal:  Mol Genet Metab       Date:  2010-07-23       Impact factor: 4.797

Review 2.  Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature.

Authors:  Jeffrey M C Lau; Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2016-06

3.  Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy.

Authors:  G Messalli; M Imbriaco; G Avitabile; R Russo; D Iodice; L Spinelli; S Dellegrottaglie; F Cademartiri; M Salvatore; A Pisani
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

4.  First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease.

Authors:  Carmela Nappi; Michele Altiero; Massimo Imbriaco; Emanuele Nicolai; Caterina Anna Giudice; Marco Aiello; Claudio Tommaso Diomiaiuti; Antonio Pisani; Letizia Spinelli; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-26       Impact factor: 9.236

5.  Agalsidase alfa (Replagal) in the treatment of Anderson-Fabry disease.

Authors:  Gregory M Pastores
Journal:  Biologics       Date:  2007-09

6.  A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report.

Authors:  Antonio Pisani; Massimo Imbriaco; Carmela Zizzo; Giuseppe Albeggiani; Paolo Colomba; Riccardo Alessandro; Francesco Iemolo; Giovanni Duro
Journal:  BMC Cardiovasc Disord       Date:  2012-06-08       Impact factor: 2.298

Review 7.  Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy.

Authors:  R P Morrissey; K J Philip; E R Schwarz
Journal:  Cardiovasc J Afr       Date:  2011 Jan-Feb       Impact factor: 1.167

8.  Myocardial T2 mapping reveals age- and sex-related differences in volunteers.

Authors:  Florian Bönner; Niko Janzarik; Christoph Jacoby; Maximilian Spieker; Bernhard Schnackenburg; Felix Range; Britta Butzbach; Sebastian Haberkorn; Ralf Westenfeld; Mirja Neizel-Wittke; Ulrich Flögel; Malte Kelm
Journal:  J Cardiovasc Magn Reson       Date:  2015-02-06       Impact factor: 5.364

9.  Atypical Distribution of Late Gadolinium Enhancement of the Left Ventricle on Cardiac Magnetic Resonance in Classical Anderson-Fabry Disease.

Authors:  Shusuke Kasuya; Masayo Suzuki; Tsutomu Inaoka; Masayuki Odashima; Tomoya Nakatsuka; Rumiko Ishikawa; Wataru Tokuyama; Hitoshi Terada
Journal:  J Belg Soc Radiol       Date:  2016-01-29       Impact factor: 1.894

10.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.